Victory Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,339
Closed -$35.2K – 2525
2026
Q1
$35.2K Buy
1,339
+20
+2% +$2.52K ﹤0.01% 2344
2025
Q4
$327K Buy
1,319
+4
+0.3% +$913 ﹤0.01% 2098
2025
Q3
$277K Sell
1,315
-10
-0.8% -$1.76K ﹤0.01% 2161
2025
Q2
$130K Sell
1,325
-1,976
-60% -$172K ﹤0.01% 2305
2025
Q1
$290K Sell
3,301
-17
-0.5% -$1.57K ﹤0.01% 2140
2024
Q4
$240K Sell
3,318
-114
-3% -$7.81K ﹤0.01% 2183
2024
Q3
$271K Sell
3,432
-80
-2% -$6.16K ﹤0.01% 2155
2024
Q2
$253K Sell
3,512
-80
-2% -$4.79K ﹤0.01% 2141
2024
Q1
$339K Sell
3,592
-312
-8% -$27.5K ﹤0.01% 2085
2023
Q4
$285K Buy
3,904
+3,644
+1,402% +$215K ﹤0.01% 2143
2023
Q3
$17.3K Buy
+260
New +$24K ﹤0.01% 2456
2022
Q4
– Sell
-593
Closed -$568K – 2643
2022
Q3
$568K Buy
+593
New +$589K ﹤0.01% 1985
2021
Q2
– Sell
-129
Closed -$95K – 2776
2021
Q1
$95K Buy
+129
New +$104K ﹤0.01% 2612
2020
Q4
– Sell
-22,125
Closed -$22M – 2557
2020
Q3
$22M Buy
22,125
+3,643
+20% +$3.86M 0.03% 751
2020
Q2
$19.2M Buy
18,482
+1,046
+6% +$1.05M 0.03% 800
2020
Q1
$14.2M Buy
17,436
+1,423
+9% +$1.49M 0.02% 792
2019
Q4
$20M Buy
16,013
+1,231
+8% +$1.98M 0.02% 823
2019
Q3
$19.9M Buy
14,782
+2,675
+22% +$4.26M 0.03% 793
2019
Q2
$21.5M Buy
12,107
+1,349
+13% +$2.06M 0.04% 594
2019
Q1
$18.6M Buy
+10,758
New +$17.9M 0.04% 588

Other funds holding GOSS

Victory Capital Management's GOSS Position: Q2 2026 in Review

Victory Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 1,339 shares — an estimated $35.2K sold.

Victory Capital Management first reported a position in GOSS in Q1 2019 and held it in 20 quarters. The position peaked at $22M in Q3 2020. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Victory Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Victory Capital Management sold 1,339 Gossamer Bio shares in Q2 2026, an estimated $35.2K.
  • Victory Capital Management first reported a position in Gossamer Bio in Q1 2019 and held it in 20 quarters.
  • Victory Capital Management's Gossamer Bio position peaked at $22M in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.